Dietary Supplement
β-glucan
β-glucan is a dietary supplement with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting133%
unknown267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
NCT04936529
unknownnot_applicable
Impact of ß-glucan Supplementation on Subjective Appetite and Gastrointestinal Appetite Hormones.
NCT05981404
unknownnot_applicable
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
NCT04387682
Clinical Trials (3)
Showing 3 of 3 trials
NCT04936529Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
NCT05981404Not Applicable
Impact of ß-glucan Supplementation on Subjective Appetite and Gastrointestinal Appetite Hormones.
NCT04387682Not Applicable
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3